INTERCURE LOGO - White Backround.png
UPDATE - InterCure Opens in Jerusalem the First “LEMONNADE” Branded Pharmacy
May 03, 2021 12:16 ET | InterCure Ltd.
This is the first branch under the “LEMONNADE” brand (from the Cookies family) outside of North America LEMONNADE Jerusalem is another flagship branch in InterCure's leading, medical cannabis...
INTERCURE LOGO - White Backround.png
InterCure Opens in Jerusalem the First “LEMONNADE” Branded Pharmacy
May 03, 2021 09:09 ET | InterCure Ltd.
This is the first branch under the “LEMONNADE” brand (from the Cookies family) outside of North America LEMONNADE Jerusalem is another flagship branch in InterCure's leading, medical cannabis...
SUB-logo.png
Subversive Acquisition LP Closes Transaction With InterCure, Israel’s Leading and Fastest-Growing Cannabis Company
April 23, 2021 18:55 ET | Subversive Acquisition LP
InterCure is the Most Well-Capitalized Cannabis Company in Israel and is Positioned to Consolidate the Israeli Market and Further Expand Across Europe Combined Company led by Chairman and Former...
SUB-logo.png
Subversive Acquisition LP Provides Update on Qualifying Transaction With InterCure, Israel’s Leading and Fastest-Growing Cannabis Company
April 21, 2021 00:31 ET | Subversive Acquisition LP
Subversive Acquisition LP Has Met All Conditions of Closing and Expects to Close on or Before Friday April 23, 2021 SPAC Restricted Voting Units Currently Trade on the TSX Under the Symbol “SVX.U”...
SUB-logo.png
Subversive Acquisition LP Provides Update on Qualifying Transaction
April 10, 2021 21:58 ET | Subversive Acquisition LP
TORONTO, April 10, 2021 (GLOBE NEWSWIRE) -- SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that closing of its qualifying transaction to combine with...
SUB-logo.png
Subversive Acquisition LP Announces Extension of Permitted Timeline for Completion of Its Qualifying Transaction
April 08, 2021 20:52 ET | Subversive Acquisition LP
TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that the date by which SVX has to consummate its qualifying...
SUB-logo.png
Subversive Acquisition LP Announces Unitholder Approval of Qualifying Transaction With InterCure, Israel’s Leading and Fastest-Growing Cannabis Company
April 06, 2021 14:35 ET | Subversive Acquisition LP
TORONTO, April 06, 2021 (GLOBE NEWSWIRE) -- SUBVERSIVE ACQUISITION LP (TSX: SVX.U NEO: SVX.U OTCQX: SBVRF) (“SVX”) announced today that that its unitholders have overwhelmingly approved its...
SUB-logo.png
Subversive Acquisition LP Announces InterCure’s Agreement With Cookies to Expand the Iconic Cannabis Brand Across Europe
April 06, 2021 09:23 ET | Subversive Acquisition LP
TORONTO, April 06, 2021 (GLOBE NEWSWIRE) -- SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that InterCure Ltd. (dba Canndoc) (TASE: INCR) (“InterCure”),...
SUB-logo.png
Subversive Acquisition LP Announces InterCure’s Letter of Intent Relating to the Acquisition of a Multi-National Medical Cannabis Producer, Better Holdings
April 05, 2021 10:07 ET | Subversive Acquisition LP
InterCure Signs Letter of Intent with Cann Pharmaceutical Ltd. Acquisition Strengthens InterCure’s Position as the Largest Cannabis Company Outside of North America TORONTO, April 05, 2021 ...
SUB-logo.png
Subversive Acquisition LP Announces InterCure’s Expansion in Europe
April 01, 2021 11:13 ET | Subversive Acquisition LP
InterCure to expand its operations into Austria and Luxembourg Medicann, InterCure’s JV Partner, has committed a €10 million investment into InterCure's Austrian subsidiary Transaction approved by...